1. Introduction
===============

1.1. Background
---------------

Angina pectoris is a clinical syndrome characterized by insufficient blood supply to the coronary arteries, sudden myocardial ischemia, and hypoxia, with episodic chest pain or chest discomfort.^\[[@R1],[@R2]\]^ Angina is the pain felt by the heart\'s ischemic reflex to the surface of the body. It is characterized by paroxysmal anterior chest and compression pain.^\[[@R3],[@R4]\]^ It can be accompanied by other symptoms. The pain is mainly located in the back of the sternum and can be radiated to the anterior and left upper limbs.^\[[@R5]\]^ Or emotional excitement often occurs, each episode lasts for 3 to 5 minutes, can be done once a few days, or several times a day, rest or disappear with nitrate preparations.^\[[@R6]--[@R8]\]^ The disease is more common in men, most of them older than 40 years, tired, emotional, full of food, cold, rainy weather, acute circulatory failure, among others,^\[[@R10]\]^ are common causes. There are many classification methods for angina pectoris, which are not unified at home and abroad.^\[[@R11]\]^ In recent years, angina pectoris has been classified into 3 categories according to the World Health Organization\'s "Name and Diagnostic Criteria for Ischemic Heart Disease."^\[[@R12]\]^ One type is exertional angina pectoris, which is divided into first-onset angina pectoris, stable angina pectoris, and worsening angina pectoris, also known as progressive angina or unstable angina; the second type is spontaneous angina pectoris, which is divided into lying Type angina pectoris, variant angina pectoris, intermediate syndrome, post-infarction angina pectoris; 3 types of mixed angina pectoris.^\[[@R13]\]^

The direct cause of angina pectoris is the absolute or relative deficiency of myocardial blood supply; therefore, various reductions in myocardial blood (blood oxygen) supply (such as intravascular thrombosis, vasospasm) and increased oxygen consumption (such as exercise, increased heart rate) factors can induce angina.^\[[@R14]\]^ Myocardial blood supply is mainly due to coronary heart disease. Sometimes, other types of heart disease or uncontrolled high blood pressure can also cause angina. There is a need to confirm the diagnosis by x-ray, electrocardiogram, selective coronary angiography.^\[[@R15]\]^

Acupuncture is an integral part of traditional Chinese medicine. According to reports in the literature, acupuncture can relieve angina symptoms and reduce the frequency of angina and pain intensity in patients with angina pectoris.^\[[@R16]\]^ After preliminary searches and database analysis, we found that the frequency of randomized controlled trials of acupuncture for angina pectoris was increasing.^\[[@R17],[@R18]\]^ Previous clinical trials have shown that acupuncture can relieve symptoms and improve the quality of life of patients.^\[[@R19]\]^ These effects persist in angina pectoris patients. However, due to the size of the clinical center and the limited number of samples, the current level of evidence-based medical evidence is still insufficient. Therefore, we hope to evaluate the effectiveness and safety of acupuncture in the treatment of angina pectoris through meta-analysis, and provide a sufficient basis for its clinical application.^\[[@R20]\]^

2. Methods
==========

This systematic review protocol has been registered on PROSPERO CRD42019138003 (<https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=138003>). The protocol follows the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol statement guidelines. We will describe the changes in our full review if needed.

2.1. Inclusion criteria for study selection
-------------------------------------------

### 2.1.1. Types of studies

We will gather all studies of acupuncture on treating angina pectoris: a systematic review and meta-analysis which, no matter whether they have been published or not, base on the method of RCT (randomized controlled trial). The language is limited to Chinese and English. Non-RCTs quasi-RCTs, series of case reports, and cross research will be excluded.

### 2.1.2. Types of participants

Our inclusion criteria are: meet the clinical diagnostic criteria for angina; comply with ECG and Holter diagnosis. Both the patient and the family informed the study and signed a consent form.

### 2.1.3. Types of interventions

We will adopt acupuncture treatment of angina pectoris as experimental interventions. Considering that the theory of pharmaco-acupuncture and point injection belongs to another part of TCM, so they will be considered for exclusion.

#### 2.1.3.1. Control interventions

As for control intervention, a person receiving virtual acupuncture treatment can be used as a placebo control, or as a blank control without receiving any treatment. However, once they receive acupuncture-combined drugs or other Chinese medicine, the trial will be rejected.

The following treatment comparisons will be studied:

1.  Acupuncture and no treatment

2.  Acupuncture and placebo/false acupuncture

3.  Acupuncture and drug treatment

4.  Acupuncture and other active therapies

5.  Acupuncture combined with another active therapy compared to the same treatment alone.

### 2.1.4. Types of outcome measures

The main criteria are: symptoms completely disappear; the number and duration of angina attacks decreased by more than 80%; the ECG is back to normal.

#### 2.1.4.1. Secondary outcomes

Secondary assessment criteria include: the number of angina pectoris is significantly reduced. At the same time, close attention should be paid to whether adverse reactions or adverse events occur during the experiment to comprehensively evaluate the clinical efficacy and safety of acupuncture in the treatment of angina pectoris.

### 2.1.5. Electronic searches

Database search includes: Search PubMed, Cochrane, Library, AMED, EMbase, WorldSciNet; Nature Science online and China National Knowledge Infrastructure, China Biology Medicine disc (CBMdisc). The temporal interval is limited from the time that the databases created to November 2019, and the combination of keyword and free word retrieval is adopted. The search terms include "acupuncture," "skin needle," "dermal needle," "angina pectoris," and "coronary heart disease angina pectoris." The search term in the Chinese database is the translation of the above word. The complete PubMed search strategy is summarized in Table [1](#T1){ref-type="table"}.

###### 

Search strategy used in PubMed database.

![](medi-99-e18548-g001)

### 2.1.6. Searching other resources

The manual search mainly searched for relevant literatures, earlier than the database above-mentioned, such as "China Rehabilitation Medicine Journal," "Chinese Acupuncture," "Chinese Journal of Physical Medicine and Rehabilitation," "Acupuncture Clinical Journal," and "Shanghai Acupuncture Journal."

2.2. Data collection and analysis
---------------------------------

### 2.2.1. Study identification

1.  There are 2 researchers filtering out the literature that clearly do not conform to the study such as meeting minutes dissertations reviews animal experiments and so on, which, after excluding all the retrieved documents from the duplicated literature, adopt the method of reading the title of the literature abstracts, among others. The details of selection process will be shown in the PRISMA flow chart (Fig. [1](#F1){ref-type="fig"}).

2.  The second time of screening the literature: skimming the remaining documents and filtering out unqualified documents such as case reports theoretical discussions and nonconformance of interventions.

3.  The third time of screening the literature: carefully reading the remaining documents and strictly filtering out unqualified documents such as general controlled trials, lacking control group, deficiency of random allocation, incompatible outcome indicator and the appearance of similar data, among others

4.  As for the literature that cannot be ensured, it would be confirmed by the discussion of the 2 researchers. And if they cannot reach an agreement, the third-party experts would get involved, which aims at absorbing the appropriate RCTs into the study.

![The PRISMA flow chart.](medi-99-e18548-g002){#F1}

### 2.2.2. Data extraction and management

The literature data extraction will be completed independently by 2 researchers and the data form uniformly developed by the researcher was filled out. The data extraction content includes the following:

1.  General information: article title, first author, corresponding author, time of publication research, evaluation correspondence, contact information.

2.  Research method: design pattern, ample size, random allocation, random hiding, blind method, baseline level.

3.  Participants: patients' age, sex, angina pectoris diagnostic criteria, severity, ethnicity study, location.

4.  Intervention: acupuncture, acupuncture point, period of treatment, treatment frequency.

5.  Efficacy evaluation: main observation indicators secondary observation indicators safety indicators and number of adverse reactions.

6.  Note: sources of funds, medical ethics audit, important references.

### 2.2.3. Assessment of risk of bias in included studies

As for the Literature quality evaluation, we will use the bias risk assessment tool recommended by Cochrane to assess the quality of all included literature and risk of bias (ROB). The assessment includes: sequence generation; allocation concealment; blinding of participants, personnel, and outcome assessors; incomplete outcome data; selective outcome reporting; other sources of bias. The evaluation above would be independently evaluated by 2 researchers. If there are different opinions, we discuss them. If there are still differences exist, we would consult the third appraiser. Otherwise, we need to consult with the Cochrane Professional Group for solution.

2.3. Statistical analysis
-------------------------

The meta-analysis studied in this review will adopt Rev Man5.3 and Stata13.0 statistical software. Heterogeneity test will be used for the inclusion of the study, and random- or fixed-effect models will be adopted, with *P* \< .05 as the test standard. If the heterogeneity between the results is too large, the random-effects model, which deduces the source of heterogeneity by sensitivity analysis, will be used for the rest analysis. Secondly, according to the different type of statistical data, the binary categorical variable will use the odds ratio (OR) and its 95% confidence interval (CI) as the effect analysis index. As for the continuous variable, the standardized mean difference and its 95% CI will be used as the effect analysis index. If the outcome measures only provide the means and standards deviation before or after treatment, the Mean~change~ and the SD~change~ are obtained according to the method provided in Cochrane Handbook 5.1.0: 

The forest map and funnel plot were drawn and analyzed using Rev Man5.3 software, and the funnel plot was used to analyze potential publication bias. As for the literature quality evaluation, we will use the bias risk assessment tool recommended by Cochrane to assess the quality of all included literature and ROB. The assessment includes: sequence generation; allocation concealment; blinding of participants, personnel, and outcome assessors; incomplete outcome data; selective outcome reporting; other sources of bias. The evaluation above would be independently evaluated by 2 researchers. If there are different opinions, we discuss them. If there are still differences exist, we would consult the third appraiser. Otherwise, we need to consult with the Cochrane Professional Group for solution.

### 2.3.1. Assessment of heterogeneity

We will use a *χ*^2^ test to estimate heterogeneity of both the mean difference and OR. Further analysis can be performed using the *I*^2^ test. If possible, we will also construct a forest plot for analysis. A random-effect model will be used to interpret the results if heterogeneity is statistically significant, whereas a fixed-effect model will be used if heterogeneity is not statistically significant. We will regard heterogeneity as substantial when *I*^2^ is \>50% or a low *P* value (\<.10) is reported for the *χ*^2^ test for heterogeneity.

### 2.3.2. Sensitivity analysis

We will conduct a sensitivity analysis to identify whether the conclusions are robust in the review according to the following criteria: sample size, heterogeneity qualities, and statistical model (random-effects or fixed-effects model).

### 2.3.3. Publication bias

If a result of a meta-analysis contains \>10 articles and above, we will use a funnel plot to test the risk of publication bias.

### 2.3.4. Quality of evidence

The quality of evidence for the main outcomes will also be assessed with the Grading of Recommendations Assessment, Development and Evaluation approach. The evaluation included bias risk; heterogeneity; indirectness; imprecision; publication bias. And each level of evidence will be made "very low," "low," "erate," or "high" judgment.

3. Discussion
=============

Coronary heart disease angina pectoris is a common and frequently occurring disease in internal medicine, which has caused great harm to the lives and health of the people.^\[[@R21]\]^ In recent years, the published global death cause and disease burden analysis report pointed out that the number of global coronary heart disease deaths exceeded 7 million, ranking first among 235 single-cause deaths.^\[[@R22]\]^ The results of the study show that coronary heart disease is the second leading cause of death in the Chinese population. Standardized drug interventions and revascularization treatments can achieve certain effects. However, how to further improve the clinical efficacy, reduce the incidence of cardiovascular events, improve the clinical symptoms of patients, and improve the quality of life of patients, these problems are the key issues to be resolved in the treatment of coronary heart disease angina.^\[[@R23],[@R24]\]^ Chinese medicine treatment of coronary heart disease angina, in addition to oral medication, there is acupuncture therapy. With the increasing side effects of drug use and drug resistance, acupuncture is becoming more and more popular.^\[[@R25]\]^ Acupuncture can significantly improve the vascular endothelial function and cardiac function in the animal model of myocardial ischemia in coronary heart disease, and effectively improve the blood lipid level and the expression of related proteins and inflammatory factors in coronary heart disease model animals, thus effectively delaying the progression of atherosclerosis.^\[[@R26]\]^ Evidence from basic animal studies supports the efficacy of acupuncture in the treatment of coronary heart disease with angina pectoris, and several clinical randomized controlled trials support this theory. Compared with conventional treatment, acupuncture can reduce the symptoms of angina pectoris in patients with coronary heart disease, improve electrocardiogram, reduce the amount of nitroglycerin, and improve hemodynamics.^\[[@R27]\]^

The specific mechanism of acupuncture for angina pectoris is unclear, so we will conduct a systematic review and meta-analysis to evaluate the efficacy and safety of acupuncture in the treatment of angina pectoris.^\[[@R28]\]^ The results of this study may provide a possible ranking for acupuncture treatment of angina. In addition, the scoring method will be used to assess the quality of the evidence for the primary outcome. We hope that these results will provide clinicians with the basis for acupuncture treatment of angina and provide the best choice for patient care. In addition, although this study will conduct a comprehensive search, it will not search for languages other than Chinese and English, which will lead to some bias.^\[[@R9]\]^
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